Immunization Action Coalition and the Hepatitis B Coalition

IAC EXPRESS

Previous issues index

Home page

Issue Number 524            May 9, 2005

CONTENTS OF THIS ISSUE

  1. FDA approves Boostrix, a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine intended for teens
  2. May 9-16 is the first National Hepatitis B Awareness Week; "AIM for the B" campaign is planned for the same time
  3. New: Spanish-language childhood and adolescent immunization schedule available on NIP's website
  4. Important: May 27 is the deadline for submitting abstracts for the National Viral Hepatitis Prevention Conference
  5. New: 2003 SMART BRFSS data and prevalence tables now available
  6. Updated: IAC revises some of its professional- and patient-education pieces
  7. Subscribe to more than 20 email news services using IAC's Directory of Immunization Resources
  8. New: Documents related to the Blue Ribbon Panel meeting about CDC's vaccine safety activities now online
  9. CDC Health Update announces destruction of influenza A(H2N2) samples mistakenly included with proficiency test panels
  10. Scheduled for June 13-15 in Atlanta, conference on public health law will include sessions on vaccine safety
  11. Vaccines 2005 conference to be held in Amsterdam June 13-15

----------------------------------------------------------

Back to Top

---------------------------------------------------------------

ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NIP, National Immunization Program; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
---------------------------------------------------------------

(1 of 11)
May 9, 2005
FDA APPROVES BOOSTRIX, A TETANUS TOXOID, REDUCED DIPHTHERIA TOXOID, AND ACELLULAR PERTUSSIS VACCINE INTENDED FOR TEENS

On May 3, FDA approved GlaxoSmithKline's biologics license application for Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap). Marketed as Boostrix, the single-dose product is indicated for active booster immunization against diphtheria, tetanus, and pertussis for individuals ages 10-18 years. It is anticipated that ACIP will discuss the use of this vaccine at its June 29-30 meeting.

To access the licensing action from the FDA website, go to:
http://www.fda.gov/cber/products/tdapgla050305.htm

To access the FDA approval letter, go to:
http://www.fda.gov/cber/approvltr/tdapgla050305L.htm

To access the prescribing information, go to:
http://www.fda.gov/cber/label/tdapgla050305LB.pdf

To access the FDA Talk Paper, go to:
http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01354.html
---------------------------------------------------------------

Back to Top

(2 of 11)
May 9, 2005
MAY 9-16 IS THE FIRST NATIONAL HEPATITIS B AWARENESS WEEK; "AIM FOR THE B" CAMPAIGN IS PLANNED FOR THE SAME TIME

The Hepatitis B Foundation (HBF) recently announced that the U.S. Congress has designated May 9-16 as the first National Hepatitis B Awareness Week. A public awareness campaign, "AIM for the B," sponsored by HBF and Bristol-Myers Squibb, is scheduled for the same time. The campaign includes events in four U.S. cities that have a high prevalence of chronic hepatitis B virus infection: Philadelphia, PA; New York, NY; San Jose, CA; and San Francisco, CA. Following is excerpted information from the HBF website about both the awareness week and the awareness campaign.

*********************

FIRST NATIONAL HEPATITIS B AWARENESS WEEK
May 9-16, 2005

For the first time, the U.S. Congress issued a resolution designating May 9-16, 2005, as National Hepatitis B Awareness Week. The resolution calls for Americans to observe the week with programs and activities to raise awareness about hepatitis B as an important public health concern. It also seeks to highlight the potentially life-threatening consequences of chronic hepatitis B and the urgency to seek appropriate care. . . .

The resolution specifically recognizes the need for a comprehensive public education and awareness campaign for patients and physicians in order to help increase the length and quality of life [of] those diagnosed with chronic hepatitis B. . . .

"AIM FOR THE B" CAMPAIGN SPOTLIGHTS HEPATITIS B

"AIM for the B" (Awareness, Involvement, and Mobilization for Chronic Hepatitis B) is a public awareness program that will take place May 9-16, 2005, to coincide with National Hepatitis B Awareness Week. Local physicians, patients, and third-party organizations will gather to share their experiences with the disease, and discuss the importance of early diagnosis and care. . . .

*********************

To access the announcement about National Hepatitis B Awareness Week and the text of the Congressional resolution, go to:
http://www.hepb.org/about/week.htm

To access the announcement about the "AIM for the B" campaign, go to: http://www.hepb.org/about/aim.htm
---------------------------------------------------------------

Back to Top

(3 of 11)
May 9, 2005
NEW: SPANISH-LANGUAGE CHILDHOOD AND ADOLESCENT IMMUNIZATION SCHEDULE AVAILABLE ON NIP'S WEBSITE

On April 29, NIP posted on its website a one-page Spanish-language version of the Recommended Childhood and Adolescent Immunization Schedule, United States, 2005. To access it, go to:
http://www.cdc.gov/nip/recs/child-schedule_sp.pdf
---------------------------------------------------------------

Back to Top

(4 of 11)
May 9, 2005
IMPORTANT: MAY 27 IS THE DEADLINE FOR SUBMITTING ABSTRACTS FOR THE NATIONAL VIRAL HEPATITIS PREVENTION CONFERENCE

Abstracts are being solicited for presentation at the National Viral Hepatitis Prevention Conference, which will be held December 5-9, 2005, in Washington, D.C.

The theme for the conference is "Viral Hepatitis Prevention at All Stages of Life." Presentations will be organized into the following six tracks:

  1. Perinatal and infant hepatitis B prevention
  2. Viral hepatitis prevention for children
  3. Viral hepatitis prevention for adolescents/high-risk youth
  4. Viral hepatitis prevention for adults; delivering, implementing, and evaluating prevention and control strategies and services
  5. Education, training, and outreach for viral hepatitis prevention and control
  6. Other/cross cutting: hepatitis prevention and control

Abstract submission deadline is Friday, May 27, 2005, midnight Pacific Time.

For more information, visit the conference website at http://www.nvhpc.com
---------------------------------------------------------------

Back to Top

(5 of 11)
May 9, 2005
NEW: 2003 SMART BRFSS DATA AND PREVALENCE TABLES NOW AVAILABLE

CDC's Behavioral Surveillance Branch recently announced the release of the 2003 SMART BRFSS data and prevalence tables. The SMART (Selected Metropolitan/Micropolitan Area Risk Trends) project uses the BRFSS (Behavioral Risk Factor Surveillance System) to analyze the data of selected metropolitan and micropolitan statistical areas (MMSAs) with 500 or more respondents. It now includes data from 2002 and 2003, with prevalence estimates for more than 120 MMSAs, as well as for counties within those areas.

In addition to containing the data sets and prevalence tables for MMSAs and counties, the SMART BRFSS web section includes pre-set Quick View charts that compare county, MMSA, and state data for seven select risk factors. Among the risk factors charted is the percentage of adults age 65 years and older who report not having received influenza vaccination within the past 12 months.

To access the SMART BRFSS web section, go to:
http://apps.nccd.cdc.gov/brfss-smart
---------------------------------------------------------------

Back to Top

(6 of 11)
May 9, 2005
UPDATED: IAC REVISES SOME OF ITS PROFESSIONAL- AND PATIENT-EDUCATION PIECES

IAC recently revised its professional-education piece "It's federal law! You must give your patients current Vaccine Information Statements (VISs)" and the English- and Spanish-language versions of its parent-education piece "Immunizations for Babies . . . A Guide for Parents."

1. To access a ready-to-print (PDF) version of "It's federal law! You must give your patients current Vaccine Information Statements (VISs)," go to:
http://www.immunize.org/catg.d/2027law.pdf

To access a web-text (HTML) version of it, go to:
http://www.immunize.org/catg.d/2027law.htm

2. To access a ready-to-print (PDF) version of "Immunizations for Babies . . . A Guide for Parents," go to:
http://www.immunize.org/catg.d/p4010imm.pdf

To access a web-text (HTML) version of it, go to:
http://www.immunize.org/catg.d/p4010.htm

3. To access a ready-to-print (PDF) version of "Vacunas para Bebes . . . Una guia para los padres," go to:
http://www.immunize.org/catg.d/p4010-01imm.pdf

To access a web-text (HTML) version of it, go to:
http://www.immunize.org/catg.d/p4010-01.htm
---------------------------------------------------------------

Back to Top

(7 of 11)
May 9, 2005
SUBSCRIBE TO MORE THAN 20 EMAIL NEWS SERVICES USING IAC'S DIRECTORY OF IMMUNIZATION RESOURCES

IAC's recently revised Directory of Immunization Resources now includes current information about more than 20 email news services (such as CDC's MMWR and the National Network for Immunization Information's "Immunization Newsbriefs") that focus on various aspects of immunization. The email news services listed include those produced by U.S. government agencies, professional societies, and nonprofits, as well as by international nonprofits, non-governmental agencies, and others. Each entry includes a brief description of a news service and a URL that links to subscription information.

To access the email news services portion of IAC's Directory of Immunization Resources, go to:
http://www.immunize.org/resources/e-mail.asp

To access the complete directory, go to:
http://www.immunize.org/resources
---------------------------------------------------------------

Back to Top

(8 of 11)
May 9, 2005
NEW: DOCUMENTS RELATED TO THE BLUE RIBBON PANEL MEETING ABOUT CDC'S VACCINE SAFETY ACTIVITIES NOW ONLINE

CDC's Office of the Chief Science Officer recently announced that on April 27 the CDC website posted two documents related to the Blue Ribbon Panel meeting that assessed CDC's vaccine safety activities. The documents are the Blue Ribbon Panel Meeting Summary Report and the Summary Report on Public Comments.

To access the Blue Ribbon Panel Meeting Summary Report, go to:
http://www.cdc.gov/od/ads/brpr/brprsumm.htm

To access the Summary Report on Public Comments, go to:
http://www.cdc.gov/od/ads/brpr/brprcomm.htm
---------------------------------------------------------------

Back to Top

(9 of 11)
May 9, 2005
CDC HEALTH UPDATE ANNOUNCES DESTRUCTION OF INFLUENZA A(H2N2) SAMPLES MISTAKENLY INCLUDED WITH PROFICIENCY TEST PANELS

On May 3, CDC released an official CDC Health Update that reported that all influenza A(H2N2) samples that were mistakenly included with laboratory proficiency test panels distributed to U.S. and international laboratories from October 2004 through March 2005 have been accounted for and destroyed. In addition, there have been no confirmed reports of H2N2-related illness associated with possible exposure to the samples. The Department of Health and Human Services and WHO are continuing investigations to determine how the situation occurred and how to prevent similar incidents from occurring in the future.

Titled "CDC Health Update: Destruction of influenza A(H2N2) proficiency testing samples; interim guidance for Biosafety Level 3-enhanced biocontainment for work with human influenza A(H2N2) viruses," the update is available on the website of the Health Alert Network (HAN).

To access a ready-to-print (PDF) version of it, go to:
http://www.cdc.gov/flu/pdf/han050305.pdf

To access a web-text (HTML) version, go to:
http://www.cdc.gov/flu/han050305.htm
---------------------------------------------------------------

Back to Top

(10 of 11)
May 9, 2005
SCHEDULED FOR JUNE 13-15 IN ATLANTA, CONFERENCE ON PUBLIC HEALTH LAW WILL INCLUDE SESSIONS ON VACCINE SAFETY

CDC published "Notice to Readers: Fourth Annual Conference on Public Health Law--June 13-15, 2005" in the May 6 issue of MMWR. The notice is reprinted below in its entirety.

***********************

The CDC Public Health Law Program and the American Society of Law, Medicine, and Ethics, along with collaborating organizations, are sponsoring the fourth annual conference on "The Public's Health and the Law in the 21st Century," June 13-15, 2005, at the Sheraton Midtown Atlanta Hotel at Colony Square in Atlanta, Georgia. The conference will focus on innovative legal tools for improved public health, with emphasis on information participants can use in day-to-day practice.

Participants and faculty include public health practitioners and medical professionals, attorneys, judges, elected officials, emergency management and law enforcement professionals, and researchers. Speakers and faculty will include representatives from The Robert Wood Johnson Foundation, World Health Organization, American Medical Association, Public Health Service, Association of State and Territorial Health Officials, Georgetown University Law Center, Center for Genetics and Health Policy at Vanderbilt University, and Cable News Network.

Sessions will cover legal and policy issues, including the following: public health emergencies, hospital infection control, quarantine, migration, obesity and cardiovascular disease, domestic violence and sexual victimization of youth, alcohol-related child motor-vehicle injury, newborn screening, vaccine safety, use of drugs in school settings, and use of international trade agreements for public health purposes. Continuing education credits will be offered.

Final day for early registration is May 10. Additional information is available at
http://www.phppo.cdc.gov/od/phlp/conference/con2005_overview.asp or by email from KMcCarthy2@cdc.gov

***********************

To access a web-text (HTML) version of the notice, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5417a6.htm

To access a ready-to-print (PDF) version of this issue of MMWR, go to: http://www.cdc.gov/mmwr/PDF/wk/mm5417.pdf

To receive a FREE electronic subscription to MMWR (which includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
---------------------------------------------------------------

Back to Top

(11 of 11)
May 9, 2005
VACCINES 2005 CONFERENCE TO BE HELD IN AMSTERDAM JUNE 13-15

Sponsored by IBC Life Sciences, Vaccines 2005 is planned for June 13-15 in Amsterdam. The main themes concern manufacturing, therapeutics, and regulatory updates.

For comprehensive information, including online registration, conference agenda and workshops, and accommodations, go to: http://www.ibc-lifesci.com/vaccines

 

Immunization Action Coalition1573 Selby AvenueSt. Paul MN 55104
E-mail: admin@immunize.org Web: http://www.immunize.org/
Tel: (651) 647-9009Fax: (651) 647-9131

This page was updated on May 9, 2005